Open AccessThe comparison of efficacy and safety between different doses of empagliflozin in insulin-treated type 1 diabetes mellitus patients: a systematic review and meta-analysis protocol
Author(s) -
Sumanta Saha,
Sujata Saha
Publication year - 2020
Publication title -
journal of diabetes and metabolic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.619
H-Index - 33
ISSN - 2251-6581
DOI - 10.1007/s40200-020-00544-x
Subject(s) - empagliflozin , meta analysis , medicine , protocol (science) , type 2 diabetes mellitus , diabetes mellitus , insulin , type 2 diabetes , endocrinology , alternative medicine , pathology
The proposed review aims to compare the efficacy and safety profile of empagliflozin 25 mg with its lower dosages and placebo, respectively, in insulin-treated type 1 diabetes mellitus (T1DM) patients.